Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016.

Ostrom QT, Cioffi G, Gittleman H, Patil N, Waite K, Kruchko C, Barnholtz-Sloan JS.

Neuro Oncol. 2019 Nov 1;21(Supplement_5):v1-v100. doi: 10.1093/neuonc/noz150.

PMID:
31675094
2.

Partnership for defining the impact of 12 selected rare CNS tumors: a report from the CBTRUS and the NCI-CONNECT.

Truitt G, Gittleman H, Leece R, Ostrom QT, Kruchko C, Armstrong TS, Gilbert MR, Barnholtz-Sloan JS.

J Neurooncol. 2019 Aug;144(1):53-63. doi: 10.1007/s11060-019-03215-x. Epub 2019 Jun 17.

PMID:
31209773
3.

Malignant primary brain and other central nervous system tumors diagnosed in Canada from 2009 to 2013.

Walker EV, Davis FG; CBTR founding affiliates.

Neuro Oncol. 2019 Feb 19;21(3):360-369. doi: 10.1093/neuonc/noy195.

4.

Comparative Brain and Central Nervous System Tumor Incidence and Survival between the United States and Taiwan Based on Population-Based Registry.

Chien LN, Gittleman H, Ostrom QT, Hung KS, Sloan AE, Hsieh YC, Kruchko C, Rogers LR, Wang YF, Chiou HY, Barnholtz-Sloan JS.

Front Public Health. 2016 Jul 21;4:151. doi: 10.3389/fpubh.2016.00151. eCollection 2016.

5.

Years of potential life lost for brain and CNS tumors relative to other cancers in adults in the United States, 2010.

Rouse C, Gittleman H, Ostrom QT, Kruchko C, Barnholtz-Sloan JS.

Neuro Oncol. 2016 Jan;18(1):70-7. doi: 10.1093/neuonc/nov249. Epub 2015 Oct 12.

6.

Descriptive epidemiology of primary brain and CNS tumors: results from the Central Brain Tumor Registry of the United States, 1990-1994.

Surawicz TS, McCarthy BJ, Kupelian V, Jukich PJ, Bruner JM, Davis FG.

Neuro Oncol. 1999 Jan;1(1):14-25. doi: 10.1093/neuonc/1.1.14.

7.

Italian cancer figures, report 2012: Cancer in children and adolescents.

AIRTUM Working Group; CCM; AIEOP Working Group.

Epidemiol Prev. 2013 Jan-Feb;37(1 Suppl 1):1-225. English, Italian.

8.

Descriptive epidemiology of pituitary tumors in the United States, 2004-2009.

Gittleman H, Ostrom QT, Farah PD, Ondracek A, Chen Y, Wolinsky Y, Kruchko C, Singer J, Kshettry VR, Laws ER, Sloan AE, Selman WR, Barnholtz-Sloan JS.

J Neurosurg. 2014 Sep;121(3):527-35. doi: 10.3171/2014.5.JNS131819. Epub 2014 Jun 13.

PMID:
24926650
9.

Italian cancer figures--Report 2015: The burden of rare cancers in Italy.

AIRTUM Working Group, Busco S, Buzzoni C, Mallone S, Trama A, Castaing M, Bella F, Amodio R, Bizzoco S, Cassetti T, Cirilli C, Cusimano R, De Angelis R, Fusco M, Gatta G, Gennaro V, Giacomin A, Giorgi Rossi P, Mangone L, Mannino S, Rossi S, Pierannunzio D, Tavilla A, Tognazzo S, Tumino R, Vicentini M, Vitale MF, Crocetti E, Dal Maso L.

Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 2):1-120. doi: 10.19191/EP16.1S2.P001.035. Erratum in: Epidemiol Prev. 2016 Mar-Apr;40(2):83.

10.

Do race and age vary in non-malignant central nervous system tumor incidences in the United States?

Gittleman H, Cote DJ, Ostrom QT, Kruchko C, Smith TR, Claus EB, Barnholtz-Sloan JS.

J Neurooncol. 2017 Sep;134(2):269-277. doi: 10.1007/s11060-017-2543-4. Epub 2017 Jun 30.

PMID:
28667594
11.

Incidence trends, rates, and ethnic variations of primary CNS tumors in Texas from 1995 to 2013.

Ambe SN, Lyon KA, Nizamutdinov D, Fonkem E.

Neurooncol Pract. 2018 Aug;5(3):154-160. doi: 10.1093/nop/npx030. Epub 2017 Nov 19.

12.

The epidemiology of central and extraventricular neurocytoma in the United States between 2006 and 2014.

Tish S, Habboub G, Jones J, Ostrom QT, Kruchko C, Barnholtz-Sloan JS, Recinos PF, Kshettry VR.

J Neurooncol. 2019 May;143(1):123-127. doi: 10.1007/s11060-019-03144-9. Epub 2019 Mar 11.

PMID:
30859483
13.

Adult Glioma Incidence and Survival by Race or Ethnicity in the United States From 2000 to 2014.

Ostrom QT, Cote DJ, Ascha M, Kruchko C, Barnholtz-Sloan JS.

JAMA Oncol. 2018 Sep 1;4(9):1254-1262. doi: 10.1001/jamaoncol.2018.1789.

14.

Descriptive epidemiology of primary spinal cord tumors.

Schellinger KA, Propp JM, Villano JL, McCarthy BJ.

J Neurooncol. 2008 Apr;87(2):173-9. Epub 2007 Dec 15.

PMID:
18084720
15.

Descriptive epidemiology of primary malignant and non-malignant central nervous tumors in Spain: Results from the Girona Cancer Registry (1994-2013).

Fuentes-Raspall R, Solans M, Roca-Barceló A, Vilardell L, Puigdemont M, Del Barco S, Comas R, García-Velasco A, Astudillo A, Carmona-Garcia MC, Marcos-Gragera R.

Cancer Epidemiol. 2017 Oct;50(Pt A):1-8. doi: 10.1016/j.canep.2017.07.005. Epub 2017 Jul 21.

PMID:
28738268
16.

Descriptive epidemiology of central nervous system germ cell tumors: nonpineal analysis.

Villano JL, Virk IY, Ramirez V, Propp JM, Engelhard HH, McCarthy BJ.

Neuro Oncol. 2010 Mar;12(3):257-64. doi: 10.1093/neuonc/nop029. Epub 2009 Dec 21.

17.

Epidemiology of primary brain and central nervous system tumors in Korea.

Lee CH, Jung KW, Yoo H, Park S, Lee SH.

J Korean Neurosurg Soc. 2010 Aug;48(2):145-52. doi: 10.3340/jkns.2010.48.2.145. Epub 2010 Aug 31.

18.

Brain, other central nervous system, and eye cancer.

Polednak AP, Flannery JT.

Cancer. 1995 Jan 1;75(1 Suppl):330-7.

PMID:
8001004
19.

Global incidence of malignant brain and other central nervous system tumors by histology, 2003-2007.

Leece R, Xu J, Ostrom QT, Chen Y, Kruchko C, Barnholtz-Sloan JS.

Neuro Oncol. 2017 Oct 19;19(11):1553-1564. doi: 10.1093/neuonc/nox091.

20.

Incidence of Malignant Brain and Central Nervous System Tumors in Golestan, Iran, 2004-2013.

Araghi M, Roshandel G, Hasanpour-Heidari S, Fazel A, Sedaghat SM, Pourkhani A, Kazeminejhad V, Miranda-Filho A, Bray F, Arnold M.

Arch Iran Med. 2020 Jan 1;23(1):1-6.

Supplemental Content

Support Center